NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/19/2020
Back to search
Official data from USPTO
CELLDEX THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
10/19/2020
Trademark type
Combined
Nice classes
5
Filing date
02/11/2009
Registration date
03/02/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/19/2020
Last transaction
10/19/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/12/2009
First use in commerce
01/12/2009
Drawing code
3
Owner type
03
Owner location
Hampton, NJ, US
Examiner
IMAM, AMEEN
Law office
M40
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of an oval design with a letter Y" inside separating the oval into three quadrants; the wording "CELLDEX" is to the right with the wording "THERAPEUTICS" below "CELLDEX".
Holders and representatives
Holders
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.
Representatives
Vanessa A. Ignacio, Esq. Lowenstein Sandler LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Purified proteins and pharmaceuticals for therapeutic useall for use in the treatment of cardiovascular diseaseimmune disorders and inflammation
Publications
History of USPTO decisions and trademark events.
37 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/19/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/19/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/19/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
08/31/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/02/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/06/2015
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/06/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/24/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/24/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/24/2015
E815
TEAS SECTION 8 & 15 RECEIVED
04/13/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
03/02/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/15/2009
PUBO
PUBLISHED FOR OPPOSITION
12/15/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/09/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
11/06/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/06/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
11/06/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/06/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
11/02/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/02/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
11/02/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/02/2009
ACEC
AMENDMENT FROM APPLICANT ENTERED
10/26/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/26/2009
PAPER RECEIVED
10/23/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/06/2009
GNRT
NON-FINAL ACTION E-MAILED
05/06/2009
CNRT
NON-FINAL ACTION WRITTEN
05/06/2009
DMCC
DATA MODIFICATION COMPLETED
05/04/2009
ALIE
ASSIGNED TO LIE
05/04/2009
DOCK
ASSIGNED TO EXAMINER
05/01/2009
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
02/18/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/17/2009
NWAP
NEW APPLICATION ENTERED
02/14/2009
Continuous trademark protection
Get notified about every new filing that threatens CELLDEX THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.